Enjoy complimentary customisation on priority with our Enterprise License!
The cell culture market size is estimated to grow by USD 24.8 billion at a CAGR of 13.64% between 2023 and 2028. The market plays a pivotal role in advancing biopharmaceutical production. Biopharmaceuticals, sourced from biological entities like vaccines, stem cells, gene therapies, and antibodies, are crucial in modern medicine. Stem cell-based regenerative medicine offers promising solutions for severe chronic ailments. As demand rises, especially for mammalian cell-derived products, biopharmaceutical companies are advancing production technologies like cell culture to meet market needs. Notably, the development of monoclonal antibodies like Humira and Rituxan highlights these advancements' efficacy, driving market growth. This market research and report includes market growth analysis, market growth and forecasting, key drivers, trends, and challenges during the forecasted period.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Agilent Technologies Inc.- The company offers cell culture such as Seahorse XF, 96 well and 8 well Poly-D-Lysine cell culture plates.
Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf SE, FUJIFILM Holdings Corp., General Electric Co., InvivoGen Corp., LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Understanding buying behavior in the healthcare sector is crucial amid advancements in cardiovascular disorders treatments and antibiotics research. Innovations in plastic consumables and concerns about plastic waste drive the adoption of single-use bioprocessing technologies, supported by substantial capital investments. Efforts in solid waste management and breakthroughs in tissue engineering reshape medical practices, while drug screening techniques evolve in biotechnology companies and diagnostic laboratories. Collaborations foster synergies, accelerating progress in therapeutic development and enhancing diagnostic capabilities in healthcare.
The market share growth by the consumables segment will be significant during the forecast period. The consumables used in cell culture include sera, media, and reagents.
Get a glance at the market contribution of various segments Download PDF Sample
The consumables segment was valued at USD 8.7 billion in 2018. The consumables segment is the largest revenue-generating segment in the global market because of high availability and vast applicability, and repeated usage. Another major reason for its high adoption is the low price of such products. The rise in the number of diseases among the huge population is triggering market growth as the demand is increasing. Companies are increasing investments in R&D due to the growing cell-based research and the rising demand for cell-based therapies to develop cell media, reagents, and supplements. Therefore, because of the above-mentioned reasons, there will be a rise in this segment during the forecast period.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The major factor that is accelerating the growth of the regional market is the presence of important companies such as Thermo Fisher Scientific. These companies are increasingly investing in new manufacturing facilities, which are highly equipped with the required bioprocessing units, and other necessary equipment required for cell culture. Furthermore, companies headquartered in other regions have been investing in the US to establish production sites. This will drive the regional market during the forecast period.
Research on stem cells and cancer is likely to propel the market growth due to an increase in the number of cancer cases. The increasing number of cancer cases is likely to trigger the need for cell-based therapies and vaccines. Additionally, the presence of sophisticated healthcare manufacturing facilities is likely to fuel demand. This will increase the product offerings by the companies and their visibility in the region, which in turn will increase the demand.
Advanced therapy medicinal products and viral vaccine production heavily rely on cell culture techniques, utilizing three-dimensional cell culture techniques and organoids in bioreactors, including Single-use bioreactors (SUBs), to meet the demands of biopharmaceutical development, enhancing vaccine production and drug discovery efforts while mitigating cross-contamination risk. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market's expansion is driven by the significant potential in emerging regions, particularly India, China, and South Africa, where rapid growth in pharmaceutical and biotechnology infrastructure supports the development of advanced cell culture techniques and substrates for producing viral vaccines and advanced therapy medicinal products. Manufacturers are expanding production facilities in these regions to meet the demand for vaccine production and biopharmaceutical development, leveraging technologies such as three-dimensional cell culture techniques and bioreactors.
For instance, Thermo Fisher Scientific is actively pursuing opportunities in emerging markets like China and India to boost revenue, promoting the adoption of cell-based models and organoids for drug discovery efforts. These initiatives aim to address contagious virus outbreaks and enhance therapeutic and diagnostic tools, thus mitigating cross-contamination risks and meeting operating volume requirements in both single-use and multiple-use bioreactors.
A notable trend in the market is the increasing demand for monoclonal antibodies, which are identical immune cells. These antibodies have diverse applications in fields like biology, diagnostics, and medicine, addressing conditions such as cancer, multiple sclerosis, and cardiovascular disease. The rising demand for monoclonal antibodies is spurring the development of advanced production technologies.
With the prevalence of chronic diseases, the need for antibody treatments is on the rise. Leading manufacturers like Thermo Fisher Scientific are expanding their production facilities with multiple bioreactors. Thermo Fisher Scientific utilizes cutting-edge platforms, single-use methods, and rapid contamination tests for antibody production. This growing demand for monoclonal antibodies is expected to drive the market size by increasing the need for equipment and consumables.
The market faces a significant challenge due to the expensive nature of equipment, which comprises two key segments: consumables and equipment. In comparison, consumables are more cost-effective, while equipment, including CO2 incubators, bioreactors, cryostorage systems, and biosafety cabinets, entails substantial expenses. For example, a cryostorage freezer system for cell banking costs approximately USD 25,000, and a biosafety cabinet exceeds USD 9,000 in cost.
Equipment like CO2 incubators demands frequent cleaning after each incubation batch or procedure to prevent chamber contamination, which can adversely affect subsequent processes. These precision devices require meticulous attention, stable environmental conditions, and regular component maintenance, collectively increasing the total ownership costs. The high acquisition and maintenance costs may deter adoption rates, negatively impacting market growth in the forecasted period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
3D Cell Culture Market - 3D Cell Culture Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,UK,China - Size and Forecast
Cell Culture Consumables Market - Cell Culture Consumables Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, Japan - Size and Forecast
Cell Culture Media and Reagents Market - Cell Culture Media and Reagents Market Analysis North America, APAC, Europe, Rest of World (ROW) - US, Canada, Japan, China, Germany - Size and Forecast
The market is witnessing exponential growth driven by advancements in cell culture techniques and substrates, particularly in biopharmaceutical development and vaccine production. With a focus on advanced therapy medicinal products and three-dimensional cell culture techniques, researchers harness cell-based models and organoids to develop therapeutic and diagnostic tools for various applications. High-throughput screening platforms accelerate drug discovery efforts, especially in emerging and established players like Captivate Bio. Notably, the market is witnessing a surge in cell culture-based vaccine production, targeting contagious viruses such as polio, rotavirus, influenza, and emerging pandemics.
Also, the market thrives on innovations in novel therapeutics and biotechnology industry, supporting breakthroughs in cell biology research for treating cardiovascular ailments, autoimmune disorders, and neurological disorders through cell therapy. Companies like CellVovant collaborate with institutions like the University of Bristol, leveraging seed funding for drug research activities and developing therapeutic proteins. Microcarrier-based technologies optimize process development time and cost reduction, vital in global regulatory requirements within healthcare markets. Emerging countries drive growth in biopharmaceutical sectors, focusing on cell therapy market expansion and enhancing diagnostics with innovative testing kits and diagnostics segment advancements.
The market is pivotal in various medical and research applications, ranging from viral vaccines to artificial organs. With the advent of cell culture tools and 3D cell cultures and cell culture protein surface, researchers can develop functional tissues and organs for patients suffering from organ failure. Notable advancements include cell-based flu vaccines and personalized therapy, revolutionizing treatment approaches. Biopharmaceutical manufacturers leverage Single-use bioreactors (SUBs) and Single-use technologies (SUTs) for efficient production, benefiting from operating volume requirements and manufacturing cost advantages. Regulatory guidelines ensure quality and safety in the biopharmaceutical sector, while materials like Polyethylene (PE) and Polypropylene (PP) minimize waste in cell culture processes. As the market expands, emphasis on toxicology and alternative medicines drives innovation for improved patient outcomes.
Market Scope |
|
Report Coverage |
Details |
Page number |
181 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 13.64% |
Market growth 2024-2028 |
USD 24.8 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
11.55 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, China, UK, Germany, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf SE, FUJIFILM Holdings Corp., General Electric Co., InvivoGen Corp., LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.